Pub. Date : 2014 Nov 18
PMID : 25407901
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | It has been suggested that EML4-ALK fusion is associated with the resistance in NSCLCs to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs), such as gefitinib and erlotinib. | Erlotinib Hydrochloride | ALK receptor tyrosine kinase | Homo sapiens |